` 600881 (Jilin Yatai Group Co Ltd) vs Shanghai Composite Comparison - Alpha Spread

600881
vs
S
Shanghai Composite

Over the past 12 months, Jilin Yatai Group Co Ltd has underperformed Shanghai Composite, delivering a return of -3% compared to the Shanghai Composite's +24% growth.

Stocks Performance
600881 vs Shanghai Composite

Loading
600881
Shanghai Composite
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
600881 vs Shanghai Composite

Loading
600881
Shanghai Composite
Difference
www.alphaspread.com

Performance By Year
600881 vs Shanghai Composite

Loading
600881
Shanghai Composite
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Jilin Yatai Group Co Ltd vs Peers

Shanghai Composite
600881
EGHT
HGJ1
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Jilin Yatai Group Co Ltd
Glance View

Market Cap
5.6B CNY
Industry
Construction

Jilin Yatai Group Co., Ltd. stands as a multifaceted conglomerate, deeply entrenched in the economic landscape of China with a robust emphasis on construction materials, real estate, and pharmaceuticals. Founded in the early 1990s, the company steadily carved its niche in the industrial sector, beginning with the production of cement—a pivotal material for China's infrastructure boom. Over the years, Jilin Yatai expanded its portfolio, strategically diversifying into industries that not only complemented its core business but also capitalized on emerging market trends. The real estate division evolved into a significant revenue driver, leveraging the construction material supply chain, which allowed it to develop residential and commercial properties efficiently. This vertical integration enabled the company to maintain a competitive edge, managing cost structures while ensuring quality and reliability in project delivery. In a bid to further consolidate its position and mitigate risks inherent in the cyclical nature of construction and real estate, Jilin Yatai ventured into the pharmaceutical sector. This bold move introduced a new pillar of growth, aimed at capitalizing on the rising demand for healthcare products and services in China. The company's pharmaceutical arm focuses on the development, manufacturing, and distribution of various medicinal products, stretching its market influence to encompass both domestic and international arenas. By adopting a strategy of diversification that effectively balances high-growth industries, Jilin Yatai has developed a multifaceted approach to revenue generation. This approach not only underpins its sustained financial health but also allows it to remain adaptable and resilient in the face of economic fluctuations.

Intrinsic Value
2.14 CNY
Undervaluation 19%
Intrinsic Value
Price
Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett